ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980